Lentiviral-mediated Delivery of SiRNAs for Antiviral Therapy

Overview

Journal Gene Ther

Date 2006 Jan 7

PMID 16397511

Citations 39

Authors

K V Morris

J J Rossi

Affiliations

Soon will be listed here.

Abstract

Lentiviral vectors portend a promising system to deliver antiviral genes for treating viral infections such as HIV-1 as they are capable of stably transducing both dividing and nondividing cells. Recently, small interfering RNAs (siRNAs) have been shown to be quite efficacious in silencing target genes. RNA interference is a natural mechanism, conserved in nature from Yeast to Humans, by which siRNAs operate to specifically and potently down regulate the expression of a target gene either transcriptionally (targeted to DNA) or post-transcriptionally (targeted to mRNA). The specificity and relative simplicity of siRNA design insinuate that siRNAs will prove to be favorable therapeutic agents. Since siRNAs are a small nucleic acid reagents, they are unlikely to elicit an immune response and genes encoding these siRNAs can be easily manipulated and delivered by lentiviral vectors to target cells. As such, lentiviral vectors expressing siRNAs represent a potential therapeutic approach for the treatment of viral infections such as HIV-1. This review will focus on the development, lentiviral based delivery, and the potential therapeutic use of siRNAs in treating viral infections.

Citing Articles

Transduction Efficiency of Zika Virus E Protein Pseudotyped HIV-1 and Its Oncolytic Activity Tested in Primary Glioblastoma Cell Cultures.

Formanski J, Ngo H, Grunwald V, Pohlking C, Jonas J, Wohlers D Cancers (Basel). 2024; 16(4).

PMID: 38398205 PMC: 10887055. DOI: 10.3390/cancers16040814.

Engineering siRNA therapeutics: challenges and strategies.

Ali Zaidi S, Fatima F, Zaidi S, Zhou D, Deng W, Liu S J Nanobiotechnology. 2023; 21(1):381.

PMID: 37848888 PMC: 10583313. DOI: 10.1186/s12951-023-02147-z.

Optimal delivery of RNA interference by viral vectors for cancer therapy.

Wong B, Birtch R, Rezaei R, Jamieson T, Crupi M, Diallo J Mol Ther. 2023; 31(11):3127-3145.

PMID: 37735876 PMC: 10638062. DOI: 10.1016/j.ymthe.2023.09.012.

The Role of Selenium Nanoparticles in the Treatment of Liver Pathologies of Various Natures.

Goltyaev M, Varlamova E Int J Mol Sci. 2023; 24(13).

PMID: 37445723 PMC: 10341905. DOI: 10.3390/ijms241310547.

The Dual Role of AQP4 in Cytotoxic and Vasogenic Edema Following Spinal Cord Contusion and Its Possible Association With Energy Metabolism via COX5A.

Huang Y, Li S, Zhou X, Zhang L, Chen G, Wang T Front Neurosci. 2019; 13:584.

PMID: 31258460 PMC: 6587679. DOI: 10.3389/fnins.2019.00584.

References

Mallory A, Ely L, Smith T, Marathe R, Anandalakshmi R, Fagard M . HC-Pro suppression of transgene silencing eliminates the small RNAs but not transgene methylation or the mobile signal. Plant Cell. 2001; 13(3):571-83. PMC: 135514. DOI: 10.1105/tpc.13.3.571. View

Pal-Bhadra M, Bhadra U, Birchler J . RNAi related mechanisms affect both transcriptional and posttranscriptional transgene silencing in Drosophila. Mol Cell. 2002; 9(2):315-27. DOI: 10.1016/s1097-2765(02)00440-9. View

Quinonez R, Sutton R . Lentiviral vectors for gene delivery into cells. DNA Cell Biol. 2003; 21(12):937-51. DOI: 10.1089/104454902762053873. View

Amado R, Mitsuyasu R, Rosenblatt J, Ngok F, Bakker A, Cole S . Anti-human immunodeficiency virus hematopoietic progenitor cell-delivered ribozyme in a phase I study: myeloid and lymphoid reconstitution in human immunodeficiency virus type-1-infected patients. Hum Gene Ther. 2004; 15(3):251-62. DOI: 10.1089/104303404322886101. View

Goujon C, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix J, Cimarelli A . Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells. J Virol. 2003; 77(17):9295-304. PMC: 187397. DOI: 10.1128/jvi.77.17.9295-9304.2003. View

Gervaix A, Schwarz L, Law P, Ho A, Looney D, Lane T . Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals. Hum Gene Ther. 1998; 8(18):2229-38. DOI: 10.1089/hum.1997.8.18-2229. View

Westerhout E, Ooms M, Vink M, Das A, Berkhout B . HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 2005; 33(2):796-804. PMC: 548362. DOI: 10.1093/nar/gki220. View

Jacque J, Triques K, Stevenson M . Modulation of HIV-1 replication by RNA interference. Nature. 2002; 418(6896):435-8. PMC: 9524216. DOI: 10.1038/nature00896. View

Johansen L, Carrington J . Silencing on the spot. Induction and suppression of RNA silencing in the Agrobacterium-mediated transient expression system. Plant Physiol. 2001; 126(3):930-8. PMC: 1540124. DOI: 10.1104/pp.126.3.930. View

10.

Banerjea A, Li M, Bauer G, Remling L, Lee N, Rossi J . Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages. Mol Ther. 2003; 8(1):62-71. DOI: 10.1016/s1525-0016(03)00140-0. View

11.

Greber U, Fassati A . Nuclear import of viral DNA genomes. Traffic. 2003; 4(3):136-43. DOI: 10.1034/j.1600-0854.2003.00114.x. View

12.

White S, Renda M, Nam N, Klimatcheva E, Zhu Y, Fisk J . Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol. 1999; 73(4):2832-40. PMC: 104041. DOI: 10.1128/JVI.73.4.2832-2840.1999. View

13.

Nishikura K . A short primer on RNAi: RNA-directed RNA polymerase acts as a key catalyst. Cell. 2001; 107(4):415-8. DOI: 10.1016/s0092-8674(01)00581-5. View

14.

Liu J, Valencia-Sanchez M, Hannon G, Parker R . MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat Cell Biol. 2005; 7(7):719-23. PMC: 1855297. DOI: 10.1038/ncb1274. View

15.

Llave C, Kasschau K, Carrington J . Virus-encoded suppressor of posttranscriptional gene silencing targets a maintenance step in the silencing pathway. Proc Natl Acad Sci U S A. 2000; 97(24):13401-6. PMC: 27236. DOI: 10.1073/pnas.230334397. View

16.

Bosher J, Dufourcq P, Sookhareea S, Labouesse M . RNA interference can target pre-mRNA: consequences for gene expression in a Caenorhabditis elegans operon. Genetics. 1999; 153(3):1245-56. PMC: 1460805. DOI: 10.1093/genetics/153.3.1245. View

17.

Castanotto D, Rossi J . Construction and transfection of PCR products expressing siRNAs or shRNAs in mammalian cells. Methods Mol Biol. 2004; 252:509-14. DOI: 10.1385/1-59259-746-7:509. View

18.

Paddison P, Caudy A, Sachidanandam R, Hannon G . Short hairpin activated gene silencing in mammalian cells. Methods Mol Biol. 2004; 265:85-100. DOI: 10.1385/1-59259-775-0:085. View

19.

Montgomery M, Xu S, Fire A . RNA as a target of double-stranded RNA-mediated genetic interference in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 1998; 95(26):15502-7. PMC: 28072. DOI: 10.1073/pnas.95.26.15502. View

20.

Morris K, Chung C, Witke W, Looney D . Inhibition of HIV-1 replication by siRNA targeting conserved regions of gag/pol. RNA Biol. 2006; 2(1):17-20. DOI: 10.4161/rna.2.1.1198. View